Nolomirole hydrochloride

Drug Profile

Nolomirole hydrochloride

Alternative Names: CHF 1035

Latest Information Update: 09 Jan 2002

Price : $50

At a glance

  • Originator Chiesi
  • Class Cardiotonics; Small molecules; Tetrahydronaphthalenes; Vasodilators
  • Mechanism of Action Alpha 2 adrenergic receptor agonists; Dopamine D2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Heart failure

Most Recent Events

  • 09 Jan 2002 CHF 1035 is now called Nolomirole hydrochloride
  • 14 Nov 2000 A clinical study has been added to the Heart Failure pharmacodynamics section
  • 20 Feb 1997 Phase-III clinical trials for Congestive heart failure in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top